Literature DB >> 21575131

Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia.

J C Boles, N S Key, R Kasthuri, A D Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21575131     DOI： 10.1111/j.1538-7836.2011.04345.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

Review 1.  Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.

Authors:  Carlo Bonfanti; Silvia Crestani; Francesco Frattini; Cinzia Sissa; Massimo Franchini
Journal:  Blood Transfus       Date:  2014-12-17       Impact factor: 3.443

2.  Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  Peter Collins; Francesco Baudo; Paul Knoebl; Hervé Lévesque; László Nemes; Fabio Pellegrini; Pascual Marco; Lilian Tengborn; Angela Huth-Kühne
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

Review 3.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

4.  Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.

Authors:  C Leissinger; C D Josephson; S Granger; B A Konkle; R Kruse-Jarres; M V Ragni; J M Journeycake; L Valentino; N S Key; J C Gill; K R McCrae; E J Neufeld; C Manno; L Raffini; K Saxena; M Torres; V Marder; C M Bennett; S F Assmann
Journal:  Thromb Haemost       Date:  2014-06-12       Impact factor: 5.249

Review 5.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443

6.  Successful Treatment of Acquired Hemophilia A with Bortezomib Plus Low Dose Rituximab in a Patient with Renal Failure and Severe Pneumonia.

Authors:  Yin Zhou; Yan Zhang; Zhe Zhuang; Yanbin Zhang
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-03       Impact factor: 0.900

7.  Anti-CD20 monoclonal antibodies: reviewing a revolution.

Authors:  J M L Casan; J Wong; M J Northcott; S Opat
Journal:  Hum Vaccin Immunother       Date:  2018-09-06       Impact factor: 3.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.